Christian Theilacker
Overview
Explore the profile of Christian Theilacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang C, Begier E, Hagel S, Ankert J, Wang L, Schwarz C, et al.
J Infect
. 2025 Feb;
90(3):106440.
PMID: 39952477
Background: RSV is a leading cause of ARI, including CAP, in older adults. Data available often underestimate RSV-related ARI incidence. We estimated RSV-related ARI hospitalization incidence from a prospective CAP...
2.
Runow E, Valeur F, Torisson G, Hansen K, Theilacker C, Riesbeck K, et al.
BMC Infect Dis
. 2025 Jan;
25(1):80.
PMID: 39825229
Background: Community-acquired pneumonia (CAP) was one of the most common causes of death in the European Union in 2017. Severity and mortality of CAP increase with age and an aging...
3.
Le Bel J, Pinot J, Alfaiate T, Ecollan M, Cussac F, Pecqueur R, et al.
NPJ Prim Care Respir Med
. 2025 Jan;
35(1):1.
PMID: 39755706
Streptococcus pneumoniae (SP) remains an important cause of community acquired pneumonia (CAP). We aimed to describe the prevalence and characteristics of outpatients with radiologically confirmed pneumococcal CAP. Between November 2017...
4.
Wieder-Finesod A, Yahav D, Rubin C, Hashkor S, Southern J, Mircus G, et al.
Clin Microbiol Infect
. 2024 Nov;
31(2):226-232.
PMID: 39551343
Objectives: The 20-valent pneumococcal conjugate vaccine (PCV20) has been introduced in Israel. Its public health benefit depends on its effect on mortality caused by PCV20 serotypes not present in 13-valent...
5.
El Safadi D, El Safadi D, Hitchins L, Hitchins L, Howard A, Howard A, et al.
J Infect Dis
. 2024 Jul;
231(1):e17-e27.
PMID: 39013016
Background: Pneumococcal carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is not well understood. Methods: Nasal wash samples from adults without close contact with young children...
6.
Grant L, Hanquet G, Sepulveda-Pachon I, Theilacker C, Baay M, Slack M, et al.
Vaccine
. 2024 Mar;
42(12):2983-2993.
PMID: 38553292
Background: The cross-protection of pneumococcal conjugate vaccines (PCV) against serotype 6C is not clearly documented, although 6C represents a substantial burden of pneumococcal disease in recent years. A systematic review...
7.
Hanquet G, Theilacker C, Vietri J, Sepulveda-Pachon I, Menon S, Gessner B, et al.
Infect Dis Ther
. 2024 Mar;
13(4):921-940.
PMID: 38498108
Introduction: Estimating the burden of lower respiratory tract infections (LRTIs) increasingly relies on administrative databases using International Classification of Diseases (ICD) codes, but no standard methodology exists. We defined best...
8.
Sepulveda-Pachon I, Dunne E, Hanquet G, Baay M, Menon S, Jodar L, et al.
J Infect Dis
. 2024 Mar;
230(3):e657-e667.
PMID: 38462672
Background: In addition to preventing pneumococcal disease, emerging evidence indicates that pneumococcal conjugate vaccines (PCVs) might indirectly reduce viral respiratory tract infections (RTIs) by affecting pneumococcal-viral interactions. Methods: We performed...
9.
Hyams C, Lahuerta M, Theilacker C, King J, Adegbite D, McGuinness S, et al.
Vaccine
. 2024 Feb;
42(7):1599-1607.
PMID: 38336560
Introduction: Pneumococcus remains a major cause of adult lower respiratory tract infections (LRTI). Few data exist on the relative contribution of serotypes included in pneumococcal vaccines to community-acquired pneumonia (CAP)...
10.
Kuhne F, Achtert K, Puschner F, Urbanski-Rini D, Schiller J, Mahar E, et al.
Expert Rev Vaccines
. 2023 Oct;
22(1):921-932.
PMID: 37881844
Objectives: Despite national recommendations for use of pneumococcal vaccines, rates of community-acquired pneumonia (CAP) and invasive pneumococcal disease (IPD) remain high in Germany. New pneumococcal conjugate vaccines (PCVs) with expanded...